RIO DE JANEIRO, BRAZIL - The race for a vaccine against the novel coronavirus reached a milestone on Tuesday. The Moderna Pharmaceutical's vaccine, one of the most promising in the world, was finally published in the prestigious New England Journal of Medicine.
Moderna confirmed what had been expected since the first news emerged two months ago. The vaccine is mostly safe and has produced immunization responses that can protect patients. The US government's health . . .